Pancreatic Cancer Research

ResearcherNational Yang Ming Chiao Tung UniversityActive in the last 2 years

Shin‐E Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7038-6146; OpenAlex author ID A5089741729. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 4

  1. Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382. Co-author DOI 10.1016/j.phymed.2024.155860↗
  2. Propensity score-matched comparison of the oncological feasibility and survival outcomes for pancreatic adenocarcinoma with robotic and open pancreatoduodenect… Last author DOI 10.1007/s00464-021-08437-7↗
  3. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal a… Co-author DOI 10.1016/j.ejca.2022.01.030↗
  4. Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis. Co-author DOI 10.18632/oncotarget.10583↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bor‐Uei Shyr · 2 shared papers, 2022–2024 · strength 0.41
  2. Kai-Ru Zhuang · 1 shared paper, 2024 · strength 0.19
  3. Shu‐Ling Fu · 1 shared paper, 2024 · strength 0.19
  4. Shih‐Ming Hsu · 1 shared paper, 2022 · strength 0.11
  5. Long‐Sheng Lu · 1 shared paper, 2022 · strength 0.11
  6. Yuan‐Hung Wu · 1 shared paper, 2022 · strength 0.11
  7. Chung‐Pin Li · 1 shared paper, 2022 · strength 0.11
  8. Yee Chao · 1 shared paper, 2022 · strength 0.11
  9. Arundhathi Arivajiagane · 1 shared paper, 2016 · strength 0.05
  10. Chih-Hong Wang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.